Diseases such as obesity, diabetes, and atherosclerosis result from multiple genetic and environmental factors, and importantly, interactions between genetic and environmental factors. Identifying susceptibility genes for these diseases using genetic and genomic technologies is accelerating, and the expectation over the next several years is that a number of genes will be identified for common diseases. However, the identification of single genes for disease has limited utility, given that diseases do not originate in complex systems from single gene changes. Further, the identification of single genes for disease may not lead directly to genes that can be targeted for therapeutic intervention. Therefore, uncovering single genes for disease in isolation of the broader network of molecular interactions in which they operate will generally limit the overall utility of such discoveries. Several integrative approaches have been developed and applied to reconstructing networks. Here we review several of these approaches that involve integrating genetic, expression, and clinical data to elucidate networks underlying disease. Networks reconstructed from these data provide a richer context in which to interpret associations between genes and disease. Therefore, these networks can lead to defining pathways underlying disease more objectively and to identifying biomarkers and morerobust points for therapeutic intervention.-Schadt, E. E., and P. Y. Lum. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J. Lipid Res. 2006. 47: 2601-2613.
Supplementary key words systems biology & networks & genetical genomicsWith the completion of the sequencing of genomes from multiple species, the challenge in the life and biomedical sciences now is to decipher the biological function of individual genes, pathways, and, more generally, biological networks that drive complex phenotypes, including common human diseases. The identification of single genes for common diseases has greatly accelerated over the past several years. With access to the complete genome sequence for a diversity of species, large-scale haplotype maps, technologies capable of screening DNA polymorphisms and gene activity on an unprecedented scale, and well-characterized human cohorts, genes explaining an appreciable risk for a number of common human diseases have been identified. Notable examples are TCF7L2, a major disease gene for common forms of type 2 diabetes (1, 2); INSIG2, a major obesity gene potentially explaining 4% of lifetime body mass index (BMI) in the human population (3); CFH, one of the more striking discoveries for age-related macular degeneration, where a number of sequence variations in complement factor H have been found to be strongly associated with this disease in a number of human studies (4-8); and ALOX5, a gene identified in human and mouse populations that predisposes to a number of diseaserelated traits, including atherosclerosis (9, 10), hyperlipidemia-dependent aortic aneurysm (11), and obesi...